Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000103

Chairperson & CEO sold 9,500 shares at an average $532.24 ($5,056,298)

  • Chairperson & CEO acquired 9,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

12 lines
Date Transaction Shares Price Value Owned after D/I
2026-07-21 Exercise or conversion : show line 1 in the form 10b5-1 +9,500 $135.42 $1,286,490 333,943 I
2026-07-21 Sale : show line 2 in the form 10b5-1 −120 $524.37 $62,924 333,823 I
2026-07-21 Sale : show line 3 in the form 10b5-1 −160 $526.24 $84,198 333,663 I
2026-07-21 Sale : show line 4 in the form 10b5-1 −240 $527.46 $126,590 333,423 I
2026-07-21 Sale : show line 5 in the form 10b5-1 −509 $529.55 $269,541 332,914 I
2026-07-21 Sale : show line 6 in the form 10b5-1 −1,926 $530.50 $1,021,743 330,988 I
2026-07-21 Sale : show line 7 in the form 10b5-1 −2,605 $531.52 $1,384,598 328,383 I
2026-07-21 Sale : show line 8 in the form 10b5-1 −360 $532.47 $191,688 328,023 I
Open-market sales · 9,500 sh · avg $532.24 · $5,056,298

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-07-21 Exercise or conversion : show line 13 in the form 10b5-1 Stock Option −9,500 303,410 I
Loading xslF345X06/primarydocument.xml…